From Reactive Audits to Predictive Analytics

Bridging the Biopharma Valley of Death: How Predictive AI is Reducing Time to Trial Commercialization

The biopharma landscape is one of the most cutthroat in the modern innovation economy, where an average of over $2 billion and often a full decade is invested in bringing new molecular entities to commercialization. At the same time, almost 90% of biotech clinical trials fail to make it to the market.

In drug discovery, the transition from early-phase safety trials to late-stage efficacy verification is commonly referred to as the Valley of Death.

Despite the fact that clinical trial attrition is an unavoidable element of the high-risk, high-reward drug discovery paradigm, the majority of trial failures are not due to failed biological QEDs but rather a result of improper trial setup that leads to unnecessary complications.

In order to mitigate these avoidable trial setbacks, the modern enterprise biopharma landscape is turning to predictive analytics to optimize trial logistics.

The Anatomy of Clinical Trial Friction

The high attrition rates of clinical trials are the result of the industry's reliance on reactive clinical trial management and auditors.

Trial reactivity occurs when sites experience patient retention issues or API supply disruptions, which are not detected until months into the trial course at the stage of document reconciliation.

The major sources of avoidable trial setbacks are:

Cohort Heterogeneity and Biomarker Misidentification: Enrollment of patients based on standard-of-care rather than on rigorous multi-omic biomarker identification leads to poorer treatment response segregation during phase II and III clinical trials.

API Cold-chain Disruption: Disorganization of the drug manufacturing or inventory pipeline can cause trial site closures due to a lack of required API supply.

Regulatory Documentation Delays: Management and auditing of Good Clinical Practice (GCP)/Good Manufacturing Practice (GMP) documentation at the trial, manufacturing, and distribution levels creates extreme document management burdens that reduce the rate of timely regulatory safety reviews.

The leading edge of the biopharma industry is already implementing digital transformations in clinical trial management by incorporating machine learning algorithms in place of reactive auditing.

Such analytics are utilized in the following key trial optimization areas:

Predictive Patient / Trial Matching: Machine learning algorithms enable researchers to utilize trial data and real-world evidence (RWE) in order to identify the most responsive patient cohorts for specific treatments, thus reducing attrition due to heterogeneity.

Predictive GxP Compliance Analytics: Traditional manual GCP/GMP trial auditing is subject to numerous delays and errors. Modern compliance management solutions are using natural language processing algorithms in order to detect inconsistencies in real-time.

Predictive Inventory Management: The drug discovery supply chain is exceptionally fragile, where changes in local storage conditions or weather patterns at the time of distribution can lead to site closures and patient safety risks. Predictive analytics are utilized to estimate drug supply requirements at trial sites in order to prevent shortages.

Enterprise trial analytics platforms such as PharmaFlux AI offer a robust digital infrastructure that enables biopharma researchers to combine insights from multiple interconnected trial domains and detect critical supply chain and trial management insights through automation.

Three Ways to Go From Reactive Audits to Predictive Trial Management

Biopharma enterprises looking to optimize their clinical trial logistics can begin their digital transformation with the following three steps:

Close the Data Silos Between R&D and Trial Management Databases: The ability to connect enterprise R&D data with trial management analytics drives rapid decision-making across departments.

Move from Periodic Site Audits to Continuous Data Anomaly Detection: Continuous analytics are crucial in supply chain management in order to respond to disruptions in real-time.

Replace Manual Inventory Forecasts With Predictive Algorithms: The use of predictive analytics in clinical trial inventory management helps to reduce costs incurring due to drug material waste.